Detalles de la búsqueda
1.
Outcomes from treatment of metastatic renal-cell carcinoma following failure of first-line anti-VEGF/VEGFR therapy: real-life evidence on the change of the treatment paradigm.
Anticancer Drugs
; 34(3): 413-421, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36730619
2.
Association of prior local therapy and outcomes with programmed-death ligand-1 inhibitors in advanced urothelial cancer.
BJU Int
; 130(5): 592-603, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34597472
3.
Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes.
BJU Int
; 128(2): 196-205, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33556233
4.
Lymphocytic infiltration and Chemotherapy Response Score as prognostic markers in ovarian cancer patients treated with Neoadjuvant chemotherapy.
Gynecol Oncol
; 157(3): 599-605, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32173048
5.
Management of uterine sarcomas and prognostic indicators: real world data from a single-institution.
BMC Cancer
; 18(1): 1247, 2018 Dec 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-30541504
6.
Papillary Renal Cell Carcinoma: Outcomes for Patients Receiving First-line Immune-based Combinations or Tyrosine Kinase Inhibitors from the ARON-1 Study.
Eur Urol Oncol
; 2024 Apr 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38575409
7.
Current Status of Tivozanib in the Treatment of Patients With Advanced Renal Cell Carcinoma.
Cureus
; 15(3): e35675, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37012938
8.
Inflammation and Immunity Gene Expression Patterns and Machine Learning Approaches in Association with Response to Immune-Checkpoint Inhibitors-Based Treatments in Clear-Cell Renal Carcinoma.
Cancers (Basel)
; 15(23)2023 Nov 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38067341
9.
New prognostic model in patients with advanced urothelial carcinoma treated with second-line immune checkpoint inhibitors.
J Immunother Cancer
; 11(1)2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36627145
10.
Treatment Rechallenge With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma.
Clin Genitourin Cancer
; 21(2): 286-294, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36481176
11.
Bone targeting agents, but not radiation therapy, improves survival in patients with bone metastases from advanced urothelial carcinoma receiving pembrolizumab: results from the ARON-2 study.
Clin Exp Med
; 23(8): 5413-5422, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37917218
12.
Response and Outcomes of Maintenance Avelumab After Platinum-Based Chemotherapy (PBC) in Patients With Advanced Urothelial Carcinoma (aUC): "Real World" Experience.
Clin Genitourin Cancer
; 21(5): 584-593, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37414620
13.
Clinico-Pathological Features Influencing the Prognostic Role of Body Mass Index in Patients With Advanced Renal Cell Carcinoma Treated by Immuno-Oncology Combinations (ARON-1).
Clin Genitourin Cancer
; 21(5): e309-e319.e1, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37062658
14.
Geographical differences in the management of metastatic de novo renal cell carcinoma in the era of immune-combinations.
Minerva Urol Nephrol
; 75(4): 460-470, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37530662
15.
Immunotherapy in HER2-Positive Breast Cancer: A Systematic Review.
Breast Care (Basel)
; 17(1): 63-70, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35355696
16.
Risk for Arterial Thromboembolic Events (ATEs) in Patients with Advanced Urinary Tract Cancer (aUTC) Treated with First-Line Chemotherapy: Single-Center, Observational Study.
Curr Oncol
; 29(9): 6077-6090, 2022 08 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-36135047
17.
Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma.
Clin Genitourin Cancer
; 20(6): 558-567, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36155169
18.
Response and Outcomes to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer Based on Prior Intravesical Bacillus Calmette-Guerin.
Clin Genitourin Cancer
; 20(2): 165-175, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35078711
19.
Association Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma.
Clin Genitourin Cancer
; 20(5): e440-e452, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35778337
20.
DNA Damage Repair: Predictor of Platinum Efficacy in Ovarian Cancer?
Biomedicines
; 10(1)2021 Dec 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-35052761